Suppr超能文献

高效亲和色谱法对药物-蛋白质解离的非竞争性峰衰减分析

Noncompetitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography.

作者信息

Chen Jianzhong, Schiel John E, Hage David S

机构信息

Chemistry Department, University of Nebraska, Lincoln, Nebraska 68588-0304, USA.

出版信息

J Sep Sci. 2009 May;32(10):1632-41. doi: 10.1002/jssc.200900074.

Abstract

The peak decay method is an affinity chromatographic technique that has been used to examine the dissociation of solutes from immobilized ligands in the presence of excess displacing agent. However, it can be difficult to find a displacing agent that does not interfere with detection of the eluting analyte. In this study, a noncompetitive peak decay method was developed in which no displacing agent was required for analyte elution. This method was evaluated for the study of drug-protein interactions by using it along with high-performance affinity chromatography to measure the dissociation rate constants for R- and S-warfarin from columns containing immobilized HSA. Several factors were considered in the optimization of this method, including the amount of applied analyte, the column size, and the flow rate. The dissociation rate constants for R- and S-warfarin from HSA were measured at several temperatures by this approach, giving values of 0.56 (+/-0.01) and 0.66 (+/-0.01) s(-1) at pH 7.4 and 37 degrees C. These results were in good agreement with previous values obtained by other methods. This approach is not limited to warfarin and HSA but could be employed in studying additional drug-protein interactions or other systems with weak-to-moderate binding.

摘要

峰衰减法是一种亲和色谱技术,已被用于在存在过量置换剂的情况下检测溶质与固定化配体的解离。然而,可能很难找到一种不干扰洗脱分析物检测的置换剂。在本研究中,开发了一种非竞争性峰衰减法,其中分析物洗脱不需要置换剂。通过将该方法与高效亲和色谱法结合使用,以测量R-和S-华法林从含有固定化人血清白蛋白(HSA)的柱上的解离速率常数,对该方法进行了药物-蛋白质相互作用研究的评估。在优化该方法时考虑了几个因素,包括分析物的上样量、柱尺寸和流速。通过这种方法在几个温度下测量了R-和S-华法林从HSA上的解离速率常数,在pH 7.4和37℃时得到的值分别为0.56(±0.01)和0.66(±0.01)s⁻¹。这些结果与通过其他方法获得的先前值非常一致。这种方法不仅限于华法林和HSA,还可用于研究其他药物-蛋白质相互作用或具有弱至中等结合力的其他系统。

相似文献

2
Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates.
J Chromatogr A. 2011 Apr 15;1218(15):2072-8. doi: 10.1016/j.chroma.2010.09.070. Epub 2010 Oct 16.
4
Evaluation of microcolumn stability in ultrafast affinity extraction for binding and rate studies.
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Dec 15;1187:123047. doi: 10.1016/j.jchromb.2021.123047. Epub 2021 Nov 17.
5
Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding.
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jun 15;878(20):1707-13. doi: 10.1016/j.jchromb.2010.04.028. Epub 2010 Apr 24.
6
High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths.
J Sep Sci. 2011 Aug;34(16-17):2255-63. doi: 10.1002/jssc.201100280. Epub 2011 Jun 10.
7
Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin.
J Chromatogr A. 2010 Apr 23;1217(17):2796-803. doi: 10.1016/j.chroma.2010.02.026. Epub 2010 Feb 23.

引用本文的文献

4
Evaluation of microcolumn stability in ultrafast affinity extraction for binding and rate studies.
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Dec 15;1187:123047. doi: 10.1016/j.jchromb.2021.123047. Epub 2021 Nov 17.
5
[Advances in chromatography in the study of drug-plasma protein interactions].
Se Pu. 2021 Oct;39(10):1077-1085. doi: 10.3724/SP.J.1123.2021.06028.
6
Development of an on-line immunoextraction/entrapment system for protein capture and use in drug binding studies by high-performance affinity chromatography.
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jan 1;1136:121812. doi: 10.1016/j.jchromb.2019.121812. Epub 2019 Nov 30.
7
Solid-Supported Proteins in the Liquid Chromatography Domain to Probe Ligand-Target Interactions.
Front Chem. 2019 Nov 15;7:752. doi: 10.3389/fchem.2019.00752. eCollection 2019.
8
Kinetic Analysis by Affinity Chromatography.
Front Chem. 2019 Oct 18;7:673. doi: 10.3389/fchem.2019.00673. eCollection 2019.
9
Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.
Methods. 2018 Aug 15;146:46-57. doi: 10.1016/j.ymeth.2018.02.021. Epub 2018 Mar 3.
10
Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications.
Clin Chem. 2017 Jun;63(6):1083-1093. doi: 10.1373/clinchem.2016.262253. Epub 2017 Apr 10.

本文引用的文献

1
Survey of the year 2003 commercial optical biosensor literature.
J Mol Recognit. 2005 Jan-Feb;18(1):1-39. doi: 10.1002/jmr.726.
2
Analysis of small-molecule interactions using Biacore S51 technology.
Anal Biochem. 2004 Jun 15;329(2):316-23. doi: 10.1016/j.ab.2004.03.028.
3
Mechanism of binding of warfarin enantiomers to recombinant domains of human albumin.
Arch Biochem Biophys. 2003 Jun 1;414(1):83-90. doi: 10.1016/s0003-9861(03)00173-5.
7
High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-protein binding.
J Chromatogr B Biomed Sci Appl. 2000 Feb 28;739(1):39-54. doi: 10.1016/s0378-4347(99)00445-4.
9
Determination of the diol content of chromatographic supports by capillary electrophoresis.
J Chromatogr A. 1997 Jan 17;758(2):255-61. doi: 10.1016/s0021-9673(96)00742-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验